Related Experiment Video
Updated: Jun 8, 2026
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Palliative radiotherapy: when is it worth it and when is it not?
Stephen Lutz1, Timothy Korytko, Janet Nguyen
1Department of Radiation Oncology, Blanchard Valley Regional Cancer Center, Findlay, OH, USA.
Cancer Journal (Sudbury, Mass.)
|October 5, 2010
Summary
Palliative radiotherapy offers effective symptom relief and is cost-effective. However, its effectiveness can be limited by patient, treatment, or healthcare system factors.
Area of Science:
- Oncology
- Radiotherapy
- Palliative Care
Background:
- Palliative radiotherapy, used since the late 1800s, is a cornerstone for symptom management.
- It is recognized for its success, time-efficiency, and cost-effectiveness in clinical practice.
Purpose of the Study:
- To contrast the effective applications of palliative radiotherapy with situations where its use is less beneficial.
- To identify patient, treatment, and healthcare system factors influencing the efficacy of palliative radiotherapy.
Main Methods:
- This study involves a comparative analysis of clinical scenarios.
- It reviews existing literature and case studies on palliative radiotherapy outcomes.
- Factors influencing treatment success and failure are systematically examined.
Main Results:
- Palliative radiotherapy is highly effective in numerous clinical settings.
- Ineffectiveness can arise from specific patient conditions, treatment complexities, or systemic healthcare issues.
- Identifying these limiting factors is crucial for optimizing patient care.
Conclusions:
- Palliative radiotherapy remains a valuable tool for symptom relief when applied appropriately.
- Understanding and mitigating factors that reduce its effectiveness is essential for maximizing patient benefit.
- Further research should focus on refining patient selection and treatment protocols to enhance outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...